We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – Products

Quantoom laboratory.
Product News

Gates Foundation To Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally

At the 2023 Grand Challenges Annual Meeting, Bill Gates, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries.
A close up of someone holding a glass test tube.
Product News

Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies

Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.
mRNA-Based Therapies
Compendium

mRNA Ready To Make Its Mark: Developing the mRNA Therapeutics of the Future

It was the mRNA vaccine that led the charge against SARS-CoV-2 in the recent pandemic, but now researchers are asking: what other therapeutic applications could benefit from mRNA technology?
Identifying Monoclonal Antibodies
App Note / Case Study

Discover the Latest in Protein Sequencing Technology

This application note demonstrates the successful identification of two low-abundance monoclonal antibodies using next-generation protein sequencing.
Pyrophosphatase and T7 RNA Polymerase packets.
Product News

Launch of High-Quality Enzymes Suitable for Pre-Clinical and Process Development in mRNA Vaccine

Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
Vaccine Development
Product
Advertisement

Influenza Vaccine Development and Production Solutions

Learn more about influenza vaccine solutions!
Vaccine vials.
Product News

NIH and Exothera Collaborate To Produce GMP Intranasal Vaccine Against SARS-CoV-2

The National Institutes of Health selected Exothera S.A. therapeutics to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.
Double helix structure of DNA.
Product News

Integrated DNA Technologies Launches New Respiratory Virus Panel

New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow.
An antibody.
Product News

Absolute Biotech Relaunches SCICONS™ dsRNA Antibodies and ELISA Kits

Absolute Biotech has announced the reintroduction of SCICONS™ dsRNA antibodies, used to detect dsRNA intermediates of a wide range of viruses, including chikungunya, dengue, hepatitis, rabies, rhinovirus, polio and swine fever.
INTEGRA logo.
Product News

INTEGRA Pipetting Solutions Accelerate Crucial Viral Genomics Research

The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies.
Advertisement